
CAY10602
CAS No. 374922-43-7
CAY10602( CAY10602 | CAY-10602 | CAY 10602 )
Catalog No. M18489 CAS No. 374922-43-7
CAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 42 | In Stock |
![]() ![]() |
10MG | 51 | In Stock |
![]() ![]() |
25MG | 87 | In Stock |
![]() ![]() |
50MG | 165 | In Stock |
![]() ![]() |
100MG | 293 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCAY10602
-
NoteResearch use only, not for human use.
-
Brief DescriptionCAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate.
-
DescriptionCAY10602 is a SIRT1 activator. CAY10602 was derived from high throughput screening for compounds that increase SIRT1-mediated deacetylation of a SIRT1-specific substrate. Functional assays show that CAY10602 dose-dependently suppresses the NF-κB-dependent induction of TNF-α by lipopolysaccharide in THP-1 cells, with approximately 75% inhibition achieved at 60 μM, without cytotoxicity.
-
In VitroCompounds (including CAY10602/compound 1) with SIRT1-activating properties have a significant effect on fat mobilization in differentiated adipocytes, and these compounds (including CAY10602) have antiobesity and/or antidiabetic properties. Compounds (including CAY10602) with SIRT1 activating potential exert strong suppression of TNF-α release at concentrations between 20 and 60 μM.
-
In Vivo——
-
SynonymsCAY10602 | CAY-10602 | CAY 10602
-
PathwayOthers
-
TargetOther Targets
-
RecptorSIRT1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number374922-43-7
-
Formula Weight418.44
-
Molecular FormulaC22H15FN4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : 100 mg/mL 238.98 mM
-
SMILESFc1ccc(cc1)n1c2nc3ccccc3nc2c(c1N)S(=O)(=O)c1ccccc1
-
Chemical Name1-(4-fluorophenyl)-3-(phenylsulfonyl)-1H-pyrrolo[2,3-b]quinoxalin-2-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. H?ppner S, et al. Fragmentation studies of SIRT1-activating drugs and their detection in human plasma for doping control purposes. Rapid Commun Mass Spectrom. 2013 Jan 15;27(1):35-50.
molnova catalog



related products
-
Lasmiditan
Lasmiditan, also known as COL-144 and LY573144, is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist (K1=2.21 μM) without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study.
-
6-Hydroxycoumarin
6-Hydroxycoumarin exhibits cytotoxicity against human HL60, HCT116, COLO205 cells with activity value of 35 uM, 42 uM, 37 respectively.
-
DiZPK
DiZPK is an analog of pyrrolysine and acts as a photocrosslinker.